# US 2025/0160194 A1 · Organic electroluminescent materials and devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0160194 A1
- Document ID: US20250160194A1
- Status: Published application
- Kind: A1
- Application number: 19/013,100
- Filed: 2025-01-08
- Published: 2025-05-15
- Earliest claimed: 2023-01-31
- Assignees: Universal Display Corporation
- Applicants: Universal Display Corporation
- Inventors: Alexey Borisovich DYATKIN; Jui-Yi TSAI; Wei-Chun SHIH
- Web page: https://patentgrep.com/patent/US20250160194A1

## CPC

- C07B 59/004: {Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium}
- H10K 85/342: {comprising iridium}
- C07F 15/0033: {Iridium compounds}
- C09K 11/02: Use of particular materials as binders, particle coatings or suspension media therefor
- C09K 11/06: containing organic luminescent materials
- H10K 50/12: comprising dopants
- H10K 85/40: Organosilicon compounds, e.g. TIPS pentacene
- H10K 85/622: {containing four rings, e.g. pyrene}
- H10K 85/654: {comprising only nitrogen as heteroatom (H10K85/652 takes precedence)}
- H10K 85/6572: {comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole}
- H10K 85/6574: {comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes}
- C09K 2211/1007: Non-condensed systems
- C09K 2211/1029: containing one nitrogen atom as the heteroatom
- C09K 2211/1033: with oxygen
- C09K 2211/1044: containing two nitrogen atoms as heteroatoms
- C09K 2211/1048: with oxygen
- C09K 2211/185: of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K 2101/10: Triplet emission
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE

## Abstract

A compound having a formula of Ir(LA)n(LB)m(LC)o is provided, where LA has a structure of Formula IA, LB has a structure of Formula IB, and LC is a bidentate ligand. In formula Ir(LA)n(LB)m(LC)o, Formula IA, and Formula IB: m, n, and o are integers and their sum is 3; each of Z1, Z2, Z3, Z4, and X1 to X12 is C or N; each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; the ring comprising Z3 and Z4 is a 5-membered heterocyclic ring; Y is as linking group; each R, R′, R″, R1, R2, R3, R4, and R5 is hydrogen or a General Substituent; and at least one pair of R1 or one pair of R2 are joined to form moiety I, which is a heterocyclic moiety. Formulations, OLEDs, and consumer products containing the compound are also provided.

## Claims

### Claim 1

A compound having a formula of Ir(LA)n(LB)m(LC)o, wherein:
LA has a structure of Formula IA,
LB has a structure of Formula IB,
LC is a bidentate ligand;
n is 1 or 2, m is 1 or 2, o is 0, 1, or 2, and m+n+o=3;
each of Z1, Z2, Z3, and Z4 is independently C or N;
each of X1 to X12 is independently C or N;
each of moiety A and moiety B is independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring and each ring of the polycyclic fused ring system is independently 5-membered or 6-membered carbocyclic or heterocyclic ring;
the ring comprising Z3 and Z4 is a 5-membered heterocyclic ring;
Y is selected from the group consisting of BR, BRR′, NR, PR, P(O)R, O, S, Se, C═O, C═S, C═Se, C═NR′, C═CR′R″, S═O, SO2, CR, CRR′, SiRR′, and GeRR′;
each of R1, R2, R3, R4, and R5 independently represents mono to the maximum allowable substitutions, or no substitutions;
each R, R′, R″, R1, R2, R3, R4, and R5 is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof;
any two substituents can be joined or fused to form a ring; and
at least one pair of R1 or one pair of R2 are joined to form moiety I, wherein moiety I is a heterocyclic ring or a heterocyclic fused ring system, wherein the heterocyclic ring and each ring of the heterocyclic fused ring system is independently 5-membered or 6-membered carbocyclic or heterocyclic ring.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound has a formula of Ir(LA)n(LB)m, having a structure of Formula II:
wherein:
m+n=3, and each of m and n is each independently 1 or 2.

### Claim 3 (depends on 1)

The compound of claim 1, wherein each R, R′, R″, R1, R2, R3, R4, and R5 is independently hydrogen, or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

### Claim 4 (depends on 1)

The compound of claim 1, wherein moiety B is selected from the group consisting of benzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, imidazole derived carbene, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, triazole, naphthalene, quinoline, isoquinoline, quinazoline, benzofuran, aza-benzofuran, phenanthro[3,2-b]benzofuran, benzoxazole, aza-benzoxazole, benzothiophene, aza-benzothiophene, benzothiazole, aza-benzothiazole, benzoselenophene, aza-benzoselenophene, indene, aza-indene, indole, aza-indole, benzimidazole, aza-benzimidazole, benzimidazole derived carbene, aza-benzimidazole derived carbene, benzobenzimidazole, aza-benzobenzimidazole, carbazole, aza-carbazole, dibenzofuran, aza-dibenzofuran, dibenzothiophene, aza-dibenzothiophene, quinoxaline, phthalazine, phenanthrene, aza-phenanathrene, anthracene, aza-antracene, phenanthridine, fluorene, and aza-fluorene; and/or
wherein moiety A is selected from the group consisting of imidazole, imidazole derived carbene, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, triazole, benzofuran, aza-benzofuran, phenanthro[3,2-b]benzofuran, benzoxazole, aza-benzoxazole, benzothiophene, aza-benzothiophene, benzothiazole, aza-benzothiazole, benzoselenophene, aza-benzoselenophene, indene, aza-indene, indole, aza-indole, benzimidazole, aza-benzimidazole, benzobenzimidazole, aza-benzobenzimidazole, benzimidazole derived carbene, and aza-benzimidazole derived carbene; and/or
wherein Y is selected from the group consisting of O, S, NR, CRR′, SiRR′, and Se.

### Claim 5 (depends on 1)

The compound of claim 1, wherein at least one of X1 to X12 is N or wherein each of X1 to X12 is C.

### Claim 6 (depends on 1)

The compound of claim 1, wherein moiety I is fused to ring D or ring E.

### Claim 7 (depends on 1)

The compound of claim 1, wherein moiety I is selected from the group consisting of pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, triazole, quinoline, isoquinoline, quinazoline, benzofuran, aza-benzofuran, benzoxazole, aza-benzoxazole, benzothiophene, aza-benzothiophene, benzothiazole, aza-benzothiazole, benzoselenophene, aza-benzoselenophene, indene, aza-indene, indole, aza-indole, benzimidazole, aza-benzimidazole, carbazole, aza-carbazole, dibenzofuran, aza-dibenzofuran, dibenzothiophene, aza-dibenzothiophene, quinoxaline, aza-phenanathrene, aza-antracene, phenanthridine, and aza-fluorene.

### Claim 8 (depends on 1)

The compound of claim 1, wherein at least one R3 comprises a cyclic group; and/or wherein at least one R4 comprises a cyclic group; and/or wherein at least one R5 is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, partially or fully deuterated, partially or fully fluorinated, and combinations thereof; and/or wherein two R5 are joined or fused together to form a ring.

### Claim 9 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of
wherein:
each of T1 to T4 is independently selected from N or C;
each of X13 to X16 is independently selected from N or C;
each of YA and YB is independently selected from the group consisting of BRe, BReRf, NRe, PRe, P(O)Re, O, S, Se, C═O, C═S, C═Se, C═NRe, C═CReRf, S═O, SO2, CReRf, SiReRf, and GeReRf,
each of RAA and RDE independently represents mono to the maximum allowable substitutions, or no substitutions; and
each Re, Rf, RAA, and RDE is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; sulfonyl, phosphino, selenyl, and combinations thereof; and
any two substituents can be fused or joined to form a ring.

### Claim 10 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of:
wherein:
each of X13 to X16 is independently selected from N or C;
each of YA and YB is independently selected from the group consisting of BRe, BReRf, NRe, PRe, P(O)Re, O, S, Se, C═O, C═S, C═Se, C═NRe, C═CReRf, S═O, SO2, CReRf, SiReRf, and GeReRf,
each of RAA and RDE independently represents mono to the maximum allowable substitutions, or no substitutions; and
each Re, Rf, RAA, and RDE is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; sulfonyl, phosphino, selenyl, and combinations thereof; and
any two substituents can be fused or joined to form a ring.

### Claim 11 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of LA1 to LA126, and the group consisting of LAi′-G(RA1)(RA2)(ZA)(YA), wherein i′ is an integer from 1 to 16, G is selected from G1 to G83, each of RA1 and RA2 is independently selected from R1 to R100, ZA is selected from Z1 to Z11, YA is selected from Y1 to Y12, and each of LA1-(G1)(R1)(R1)(Z1)(Y1) to LA16-(G83)(R100)(R100)(Z11)(Y12) is defined in the following LIST 3a:
LA
Structure of LA
For LA1- G(RA1)(RA2)(ZA)(YA), LA1-(G1)(R1)(R1) (Z1)(Y1) to LA1- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA2- G(RA1)(RA2)(ZA)(YA), LA2-(G1)(R1)(R1) (Z1)(Y1) to LA2- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA3- G(RA1)(RA2)(ZA)(YA), LA3-(G1)(R1)(R1) (Z1)(Y1) to LA3- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA4- G(RA1)(RA2)(ZA)(YA), LA4-(G1)(R1)(R1) (Z1)(Y1) to LA4- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA5- G(RA1)(RA2)(ZA)(YA), LA5-(G1)(R1)(R1) (Z1)(Y1) to LA5- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA6- G(RA1)(RA2)(ZA)(YA), LA6-(G1)(R1)(R1) (Z1)(Y1) to LA6- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA7- G(RA1)(RA2)(ZA)(YA), LA7-(G1)(R1)(R1) (Z1)(Y1) to LA7- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA8- G(RA1)(RA2)(ZA)(YA), LA8-(G1)(R1)(R1) (Z1)(Y1) to LA8- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA9- G(RA1)(RA2)(ZA)(YA), LA9-(G1)(R1)(R1) (Z1)(Y1) to LA9- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA10- G(RA1)(RA2)(ZA)(YA), LA10-(G1)(R1)(R1) (Z1)(Y1) to LA10- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA11- G(RA1)(RA2)(ZA)(YA), LA11-(G1)(R1)(R1) (Z1)(Y1) to LA11- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA12- G(RA1)(RA2)(ZA)(YA), LA12-(G1)(R1)(R1) (Z1)(Y1) to LA12- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA13- G(RA1)(RA2)(ZA)(YA), LA13-(G1)(R1)(R1) (Z1)(Y1) to LA13- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA14- G(RA1)(RA2)(ZA)(YA), LA14-(G1)(R1)(R1) (Z1)(Y1) to LA14- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA15- G(RA1)(RA2)(ZA)(YA), LA15-(G1)(R1)(R1) (Z1)(Y1) to LA15- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA16- G(RA1)(RA2)(ZA)(YA), LA16-(G1)(R1)(R1) (Z1)(Y1) to LA16- (G83)(R100)(R100) (Z11)(Y12) have the structure
wherein each of R1 to R100 have the structures defined in the following LIST 3b:
wherein each of G1 to G83 have the structures defined in the following LIST 3c:
wherein each of Y1 to Y12 have the structures defined in the following LIST 3d:
where #shows direction toward CRA1 in LA1-(G1)(R1)(R1)(Z1)(Y1) to LA16-(G83)(R100)(R100)(Z11)(Y12)-; and
wherein each of Z1 to Z11 have the structures defined in the following LIST 3e:
wherein LA1 to LA126 have the following structures:

### Claim 12 (depends on 1)

The compound of claim 1, wherein the compound has a formula of M(LA)p(LB)q(LC)r wherein LB and LC are each a bidentate ligand; and wherein p is 1, 2, or 3; q is 0, 1, or 2, r is 0, 1, or 2; and p+q+r is the oxidation state of the metal M.

### Claim 13 (depends on 12)

The compound of claim 12, wherein the compound has a formula selected from the group consisting of Ir(LA)3, Ir(LA)(LB)2, Ir(LA)2(LB), Ir(LA)2(LC), and Ir(LA)(LB)(LC); and wherein LA, LB, and LC are different from each other.

### Claim 14 (depends on 12)

The compound of claim 12, wherein LB and LC are each independently selected from the group consisting of the structures of LIST 4 defined herein, wherein:
T is selected from the group consisting of B, Al, Ga, and In;
K1′ is a direct bond;
each of Y1 to Y13 is independently selected from the group consisting of C and N;
Y′ is selected from the group consisting of BRe, BReRf, NRe, PRe, P(O)Re, O, S, Se, C═O, C═S, C═Se, C═NRe, C═CReRf, S═O, SO2, CReRf, SiReRf, and GeReRf,
Re and Rf can be fused or joined to form a ring;
each Ra, Rb, Rc, and Rd independently represents from mono to the maximum allowed number of substitutions, or no substitution;
each of Ra1, Rb1, Rc1, Rd1, Ra, Rb, Rc, Rd, Re, and Rf is independently a hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and
any two substituents of Ra1, Rb1, Rc1, Rd1, Ra, Rb, Rc, and Rd can be fused or joined to form a ring or form a multidentate ligand.

### Claim 15 (depends on 12)

The compound of claim 12, wherein LA can be selected from LA1 to LA126, and from LAi′-G(RA1)(RA2)(ZA)(YA), wherein i′ is an integer from 1 to 16, G is selected from G1 to G83, each of RA1 and RA2 is independently selected from R1 to R100, ZA is selected from Z1 to Z11, YA is selected from Y1 to Y12, and each of LA1-(G1)(R1)(R1)(Z1)(Y1) to LA16-(G83)(R100)(R100)(Z11)(Y12) is defined in the following LIST 3a:
LA
Structure of LA
For LA1- G(RA1)(RA2)(ZA)(YA), LA1-(G1)(R1)(R1) (Z1)(Y1) to LA1- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA2- G(RA1)(RA2)(ZA)(YA), LA2-(G1)(R1)(R1) (Z1)(Y1) to LA2- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA3- G(RA1)(RA2)(ZA)(YA), LA3-(G1)(R1)(R1) (Z1)(Y1) to LA3- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA4- G(RA1)(RA2)(ZA)(YA), LA4-(G1)(R1)(R1) (Z1)(Y1) to LA4- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA5- G(RA1)(RA2)(ZA)(YA), LA5-(G1)(R1)(R1) (Z1)(Y1) to LA5- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA6- G(RA1)(RA2)(ZA)(YA), LA6-(G1)(R1)(R1) (Z1)(Y1) to LA6- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA7- G(RA1)(RA2)(ZA)(YA), LA7-(G1)(R1)(R1) (Z1)(Y1) to LA7- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA8- G(RA1)(RA2)(ZA)(YA), LA8-(G1)(R1)(R1) (Z1)(Y1) to LA8- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA9- G(RA1)(RA2)(ZA)(YA), LA9-(G1)(R1)(R1) (Z1)(Y1) to LA9- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA10- G(RA1)(RA2)(ZA)(YA), LA10-(G1)(R1)(R1) (Z1)(Y1) to LA10- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA11- G(RA1)(RA2)(ZA)(YA), LA11-(G1)(R1)(R1) (Z1)(Y1) to LA11- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA12- G(RA1)(RA2)(ZA)(YA), LA12-(G1)(R1)(R1) (Z1)(Y1) to LA12- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA13- G(RA1)(RA2)(ZA)(YA), LA13-(G1)(R1)(R1) (Z1)(Y1) to LA13- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA14- G(RA1)(RA2)(ZA)(YA), LA14-(G1)(R1)(R1) (Z1)(Y1) to LA14- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA15- G(RA1)(RA2)(ZA)(YA), LA15-(G1)(R1)(R1) (Z1)(Y1) to LA15- (G83)(R100)(R100) (Z11)(Y12) have the structure
For LA16- G(RA1)(RA2)(ZA)(YA), LA16-(G1)(R1)(R1) (Z1)(Y1) to LA16- (G83)(R100)(R100) (Z11)(Y12) have the structure
wherein each of R1 to R100 have the structures defined in the following LIST 3b:
wherein each of G1 to G83 have the structures defined in the following LIST 3c:
wherein each of Y1 to Y12 have the structures defined in the following LIST 3d:
where #shows direction toward CRA1 in LA1-(G1)(R1)(R1)(Z1)(Y1) to LA16-(G83)(R100)(R100)(Z11)(Y12), and
wherein each of Z1 to Z11 have the structures defined in the following LIST 3e:
and
wherein LA1 to LA126 have the following structures;
and
LB can be selected from Lak, wherein k is an integer from 1 to 530, wherein:
when the compound has formula Ir(LAi)3, the compound is selected from the group consisting of Ir(LA1)3 to Ir(LA126)3,
when the compound has formula Ir(LAi)(LBk)2, the compound is selected from the group consisting of Ir(LA1)(LB1)2 to Ir(LA126)(LB530)2;
when the compound has formula Ir(LAi)2(LBk), the compound is selected from the group consisting of Ir(LA1)2(LB1) to Ir(LA126-)2(LB530);
when the compound has formula Ir(LAi′-G(RA1)(RA2)(ZA)(YA))3, the compound is selected from the group consisting of Ir(LA1-(G1)(R1)(R1)(Z1)(Y1))3 to Ir(LA16-(G83)(R100)(R100)(Z11)(Y12))3;
when the compound has formula Ir(LAi′-G(RA1)(RA2)(ZA)(YA))(LBk)2, the compound is selected from the group consisting of Ir(LA1-(G1)(R1)(R1)(Z1)(Y1))(LB1)2 to Ir(LA16-(G83)(R100)(R100)(Z11)(Y12))(LB530)2;
when the compound has formula Ir(LAi′-G(RA1)(RA2)(ZA)(YA))2(LBk), the compound is selected from the group consisting of Ir(LA1-(G1)(R1)(R1)(Z1)(Y1))2(LB1) to Ir(LA16-(G83)(R100)(R100)(Z11)(Y12))2(LB530);
wherein each LAi′-G(RA1)(RA2)(ZA)(YA) has the structure defined in the LIST 3a; and
wherein each LB1 to LB530 have the following structures:

### Claim 16 (depends on 1)

The compound of claim 1, wherein the compound is selected from the group consisting of:

### Claim 17 (depends on 1)

An organic light emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound according to claim 1.

### Claim 18 (depends on 17)

The OLED of claim 17, wherein the organic layer further comprises a host, wherein host comprises at least one chemical moiety selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, azaborinine, oxaborinine, dihydroacridine, xanthene, dihydrobenzoazasiline, dibenzooxasiline, phenoxazine, phenoxathiine, phenothiazine, dihydrophenazine, fluorene, naphthalene, anthracene, phenanthrene, phenanthroline, benzoquinoline, quinoline, isoquinoline, quinazoline, pyrimidine, pyrazine, pyridine, triazine, boryl, silyl, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

### Claim 19 (depends on 17)

The OLED of claim 17, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:
wherein:
each of J1 to J6 is independently C or N;
L′ is a direct bond or an organic linker;
each YAA, YBB, YCC, and YDD is independently selected from the group consisting of absent a bond, direct bond, O, S, Se, CRR′, SiRR′, GeRR′, NR, BR, BRR′;
each of RA′, RB′, RC′, RD′, RE′, RF′, and RG′ independently represents mono, up to the maximum substitutions, or no substitutions;
each R, R′, RA′, RB′, RC′, RD′, RE′, RF′, and RG′ is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
any two substituents can be joined or fused to form a ring; and
where possible, each unsubstituted aromatic carbon atom is optionally replaced with one or more N to form an aza-substituted ring.

### Claim 20 (depends on 1)

A consumer product comprising an organic light-emitting device comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound according to claim 1.
